Physician profile
Christopher Ayodele Jarrett
NPI 1083720916
$43,657.90
in general payments reported to CMS, 2019-2025
14 companies · $3,644 in 2025
The $3,644 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $5,711 · 2021: $1,207 · 2022: $5,667 · 2023: $2,137 · 2024: $1,553 · 2025: $3,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Travel and Lodging: $2,368 · Food and Beverage: $1,966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $2,368.18 |
| Food and Beverage | $1,965.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $41,214.82 | 2019-2025 | Gmk Sphere, Amistem, Gmk Revision |
| Shalby Advanced Technologies, INC. | $1,082.56 | 2024 | |
| Zimmer Biomet Holdings, INC. | $457.05 | 2019-2025 | Persona, G7 |
| Horizon Therapeutics Plc | $297.76 | 2019-2021 | |
| Tricoast Surgical Solutions LLC | $234.89 | 2025 | |
| Stryker Corporation | $170.65 | 2020-2022 | |
| Smith+Nephew, INC. | $55.86 | 2021-2025 | "Acticoat 4"" X 4""", Pico 7, Pico 14 |
| Ferring Pharmaceuticals INC. | $35.91 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $25.62 | 2019 | |
| Fidia Pharma USA INC. | $22.73 | 2019-2021 | |
| Heraeus Medical, LLC. | $16.19 | 2019 | |
| Endo Pharmaceuticals INC. | $15.81 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.34 | 2023 | Nuzyra |
| Abbott Laboratories | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Jarrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.